ALS trial shows novel therapy is safe

An investigational treatment for an inherited form of Lou Gehrig’s disease has passed an early phase clinical trial for safety, researchers at the School of Medicine and Massachusetts General Hospital report. A mutated protein that causes an inherited form of Lou Gehrig’s disease leads to clumps in the human cells, which are pictured.